Blog
RSS FeedPosted by Michael Wonder on 12 Apr 2016
SMC industry engagement event
12 April 2016 - The SMC are pleased to announce the date of the next industry engagement event. ...
Posted by Michael Wonder on 11 Apr 2016
SMC - April 2016 decisions news release
11 April 2016 - SMC accepts three new medicines for routine use by NHS Scotland. ...
Posted by Michael Wonder on 04 Apr 2016
Patients could suffer as drug costs threaten to bankrupt NHS
2 April 2016 - Patients may miss out on vital drugs as doctors warned that high costs could cause the health ...
Posted by Michael Wonder on 23 Mar 2016
SMC allows wider use of Gedeon Richter's Esmya (ulipristal acetate)
23 March 2016 - The Scottish Medicines Consortium has approved funding for the use across NHS Scotland of a uterine fibroid ...
Posted by Michael Wonder on 19 Mar 2016
SMC announces more forthcoming submissions
18 March 2016 - The SMC has announced forthcoming submissions for the following medicines: carfilzomib (Kyprolis), dasatinib monohydrate (Sprycel), emtricitabine with ...
Posted by Michael Wonder on 08 Mar 2016
Scotland rejects cancer drugs Opdivo and Perjeta
7 March 2016 - The SMC has rejected Opdivo as a monotherapy for the treatment of advanced melanoma, and Perjeta for ...
Posted by Michael Wonder on 07 Mar 2016
SMC - March 2016 decisions news release
7 March 2016 - The Scottish Medicines Consortium has today published advice accepting three new medicines for routine use in NHS ...
Posted by Michael Wonder on 23 Feb 2016
New medicines review - SMC event on March 21
23 February 2016 - Following the recent announcement by the Scottish Government of an independent review into access to new medicines, ...
Posted by Michael Wonder on 08 Feb 2016
February 2016 SMC decisions news release
8 February 2016 - SMC accepts treatments for breast cancer, myeloma and ADHD. ...
Posted by Michael Wonder on 02 Feb 2016
Review of NHS drugs assessment ordered
31 January 2016 - An independent review is to be carried out of the way drugs are assessed for use on ...
Posted by Michael Wonder on 13 Jan 2016
SMC announces more forthcoming submissions
13 January 2016 - The SMC has announced forthcoming submissions for the following medicines: brivaracetum (Briviact), cabazitaxel (Jevtana), crizotinib (Xalkori), febuxostat ...
Posted by Michael Wonder on 11 Jan 2016
January 2016 SMC decisions news release
11 January 2016 - The Scottish Medicines Consortium, which reviews newly licensed medicines, has today published advice accepting five new medicines ...
Posted by Michael Wonder on 21 Dec 2015
SMC announces more forthcoming submissions
21 December 2015 - The SMC has announced forthcoming submissions for the following medicines: alendronic acid (Binosto), cabazitaxel (Jevtana), ibrutinib ...
Posted by Michael Wonder on 07 Dec 2015
SMC accepts medicines for multiple myeloma and lung cancer
7 December 2015 - The Scottish Medicines Consortium has today published advice accepting five new medicines for routine use in NHS ...
Posted by Michael Wonder on 13 Nov 2015
SMC announces more forthcoming submissions
12 November 2015 - SMC has announced forthcoming submissions for the following medicines: alirocumab (Praluent), atularen (Translarna), blinatumomab (Blincyto) & ceftolozane with tazobactam (Zerbaxa). ...